Article

Updated: FDA Temporarily Removes List Of Hospitals, Providers That Received Products From Mass. Compounder

Just hours after posting it Monday, the Food and Drug Administration removed from its website a list of hospitals and doctors that had received products from the compounding pharmacy now at the center of the fungal meningitis outbreak, saying data may be incorrect.

The agency said it is working to correct the list and will repost once it is completed. Data had been supplied to the agency by the pharmacy, the New England Compounding Center in Massachusetts.

Read the full story: http://bit.ly/Rh58e8

Source: Kaiser Health News

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Alexandra M. Trevino, MD, Northwestern Medicine
Dr Carla Nester
AJMC interview with Ali Shan Hafeez and Dr Abdul Rafae Faisal | Background image credit: ipopba - stock.adobe.com
2 experts in this video
2 experts in this video
Marry Vuong, PharmD, BCPPS
Julia Rotow, MD, Dana-Farber
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo